Fragile X syndrome is the most frequent cause of intellectual disability in males, affecting 1 out of 3600 boys born. For the first time, researchers at Whitehead Institute have restored activity to the fragile X syndrome gene in affected neurons using a modified CRISPR/Cas9 system they developed that removes the methylation—the molecular tags that keep the mutant gene shut off—suggesting that this method may prove to be a useful paradigm for targeting diseases caused by abnormal methylation.
Research by the lab of Whitehead Institute Founding Member Rudolf Jaenisch, which is described online this week in the journal Cell, is the first direct evidence that removing the methylation from a specific segment within the FMR1 locus can reactivate the gene and rescue fragile X syndrome neurons.
The FMR1 gene sequence includes a series of three nucleotide (CGG) repeats, and the length of these repeats determines whether or not a person will develop fragile X syndrome: A normal version of the gene contains anywhere from 5-55 CGG repeats; versions with 56-200 repeats are considered to be at a higher risk of generating some of the syndrome’s symptoms; and those versions with more than 200 repeats will produce fragile X syndrome.
Until now, the mechanism linking the excessive repeats in FMR1 to fragile X syndrome was not well understood. But Shawn Liu, a postdoctoral researcher in Jaenisch’s lab and first author of the Cellstudy, and others thought that the methylation blanketing those nucleotide repeats might play an important role in shutting down the gene’s expression.
In order to test this hypothesis, Liu removed the methylation tags from the FMR1 repeats using a CRISPR/Cas9-based technique recently developed by him and Hao Wu, a former postdoctoral researcher in the Jaenisch lab. This technique can either add or delete methylation tags from specific stretches of DNA. Removal of the tags revived the FMR1 gene’s expression to the level of the normal gene.
“These results are quite surprising—this work produced almost a full restoration of wild type expression levels of the FMR1 gene,” says Jaenisch, who is a professor of biology at Massachusetts Institute of Technology and the senior author on the study. “Often when scientists test therapeutic interventions, they only achieve partial restoration, so these results are substantial.”
The reactivated FMR1 gene rescues neurons derived from fragile X syndrome induced pluripotent stem (iPS) cells, reversing the abnormal electrical activity associated with the syndrome. When rescued neurons were engrafted into the brains of mice, the FMR1 gene remained active in the neurons for at least three months, suggesting that the corrected methylation may be sustainable in the animal.
“We showed that this disorder is reversible at the neuron level,” says Liu. “When we removed methylation of CGG repeats in the neurons derived from fragile X syndrome iPS cells, we achieved full activation of FMR1.”
The CRISPR/Cas-9-based technique may also prove useful for other diseases caused by abnormal methylation including facioscapulohumeral muscular dystrophy and imprinting diseases.
“This work validates the approach of targeting the methylation on genes, and it will be a paradigm for scientists to follow this approach for other diseases,” says Jaenisch.
The Latest on: Fragile X syndrome
- Scientists identify genetic mechanism involved in how females inherit traits on February 20, 2019 at 11:54 am
It also determines females' susceptibility to various diseases, such as Fragile X syndrome and Rett syndrome. "The splicing mechanism is fundamental to understanding trait inheritance in females," he ... […]
- Zynerba Pharmaceuticals Appoints Pamela Stephenson to Board of Directors on February 20, 2019 at 4:00 am
This experience will be essential as we develop the market for ZYN002 in Fragile X Syndrome and await data from our ongoing pivotal CONNECT-FX study. Pamela's commercial insight will be instrumental a... […]
- Fragile X Syndrome Market CAGR, Key Players, Applications, Products and Regions Till 2025 on February 15, 2019 at 10:24 am
The Fragile X Syndrome market report gives CAGR value, Industry Chains, Upstream, Geography, End user, Application, Competitor analysis, SWOT Analysis, Sales, Revenue, Price, Gross Margin, Market Shar... […]
- ‘Editing’ of RNA may play sizeable role in autism on February 14, 2019 at 4:08 am
The process, called RNA editing, turns out to involve two proteins central to fragile X syndrome, one of the most common causes of autism. The findings suggest that stalled RNA editing is common to se... […]
- Expanded reproductive carrier screening—how can we do the most good and cause the least harm? on February 13, 2019 at 10:31 am
Examples of screening by genetic testing includes screening for cystic fibrosis, spinal muscular atrophy, and fragile X syndrome. When screening is for one or few conditions, the results of testing ar... […]
- Study reveals how one mutation causes the most common inherited intellectual disability on February 12, 2019 at 3:07 am
"Fragile X syndrome has been studied as a model of intellectual disability because in theory it's comparatively simple," says senior author Xinyu Zhao, a professor of neuroscience in the Waisman Cente... […]
- Determined mum who became advocate for young disabled people to receive Local Hero award on February 11, 2019 at 10:40 pm
In Alexandra, she's a strong voice for young people with disabilities. It all started when her son, Jack, was diagnosed with Fragile X Syndrome, a genetic disorder effecting development and cognitive ... […]
- Cell component breakdown suggests possible treatment for multiple neural disorders on February 11, 2019 at 8:08 am
"Fragile X syndrome has been studied as a model of intellectual disability because in theory it's comparatively simple," says senior author Xinyu Zhao, a professor of neuroscience in the Waisman ... […]
- Probing hyperexcitability in fragile X syndrome on February 7, 2019 at 7:42 am
Studying a model of fragile X syndrome, Emory researchers were looking at neurons displaying single spiking and multi-spiking behavior. Their findings may explain the appearance of cortical hyperexcit... […]
- Study to probe Rett syndrome treatment on February 3, 2019 at 5:03 pm
Trofinetide is also being investigated as a treatment for traumatic brain injury and Fragile X syndrome, a genetic condition that causes intellectual disability. […]
via Google News and Bing News